Experimental combo targets Chemo-Resistant cancers
Disease control
Ongoing
This study tests an experimental drug called NEO-201 combined with the immunotherapy pembrolizumab in adults with advanced solid tumors that no longer respond to chemotherapy. The trial focuses on lung, head and neck, cervical, and uterine cancers. Researchers aim to find a safe …
Phase: PHASE1, PHASE2 • Sponsor: Precision Biologics, Inc • Aim: Disease control
Last updated Jun 24, 2026 07:02 UTC